Viewing Study NCT02133560


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-03-11 @ 10:55 AM
Study NCT ID: NCT02133560
Status: COMPLETED
Last Update Posted: 2017-05-25
First Post: 2014-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of Mobile Technology for Intensive Training in Medication Management
Sponsor: Duke University
Organization:

Study Overview

Official Title: Use of Mobile Technology for Intensive Training in Medication Management
Status: COMPLETED
Status Verified Date: 2017-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Purpose: Assess whether intensive training with education and daily remote monitoring with provider involvement has a lasting positive impact on adherence to medication management. The study will seek to enroll 25 subjects with sickle cell disease or thalassemia, and less than 100% compliance for taking iron chelators in the previous three month prior to participation in the study. Subjects will be asked to monitor their daily iron chelator administration by taking a video recording of preparing it and ingesting at least one sip. Subjects will also use a medication log to record daily administration of medication, and meet with study staff monthly for educational activities. The data collected will be analyzed to describe patient adherence and comfort level with the process of daily recording of medication management. Mean percent adherence in the pre-study periods and each of the study periods will be analyzed and compared.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: